ESC Premium Access

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

Congress Session

About the speaker

Doctor Takahiro Noto

Sapporo Medical University, Sapporo (Japan)
0 follower

7 more presentations in this session

Research into the effect of sodium-glucose linked transporter inhibition in left ventricular remodelling in patients with heart failure and diabetes mellitus.

Speaker: Professor C. Lang (Dundee, GB)

Thumbnail

Diminished response to statin therapy predicts future occurrence of heart failure in patients with acute myocardial infarction

Speaker: Doctor K. Tsuda (Takatsuki, JP)

Thumbnail

Titration patterns and clinical characteristics of patients prescribed sacubitril/valsartan in the primary care and cardiology settings in germany

Speaker: Associate Professor R. Wachter (Leipzig, DE)

Thumbnail

Characteristics of heart failure patients treated with Sacubitril - Valsartan in Europe. Results from ARIADNE

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Thumbnail

Heart rate reduction by selective sinus node blocker (ivabradine) protects against detrimental hemodynamic and structural effects of iv inotrops in heart failure

Speaker: Professor P. Leszek (Warsaw, PL)

Thumbnail

Access the full session

Poster Session 1 - Chronic heart failure – Treatment

Speakers: Doctor T. Noto, Professor C. Lang, Doctor K. Tsuda, Associate Professor R. Wachter, Professor U. Zeymer...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk